These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 6798490)

  • 1. Valproic acid versus ethosuximide in the treatment of absence seizures.
    Sato S; White BG; Penry JK; Dreifuss FE; Sackellares JC; Kupferberg HJ
    Neurology; 1982 Feb; 32(2):157-63. PubMed ID: 6798490
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative study of ethosuximide and sodium valproate in the treatment of typical absence seizures (petit mal).
    Callaghan N; O'Hare J; O'Driscoll D; O'Neill B; Daly M
    Dev Med Child Neurol; 1982 Dec; 24(6):830-6. PubMed ID: 6818076
    [No Abstract]   [Full Text] [Related]  

  • 3. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy.
    Glauser TA; Cnaan A; Shinnar S; Hirtz DG; Dlugos D; Masur D; Clark PO; Capparelli EV; Adamson PC;
    N Engl J Med; 2010 Mar; 362(9):790-9. PubMed ID: 20200383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of treatment in typical absence seizures. The roles of long-term EEG monitoring and ethosuximide.
    Blomquist HK; Zetterlund B
    Acta Paediatr Scand; 1985 May; 74(3):409-15. PubMed ID: 3923777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: initial monotherapy outcomes at 12 months.
    Glauser TA; Cnaan A; Shinnar S; Hirtz DG; Dlugos D; Masur D; Clark PO; Adamson PC;
    Epilepsia; 2013 Jan; 54(1):141-55. PubMed ID: 23167925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence seizures: valproate or ethosuximide?
    Santavuori P
    Acta Neurol Scand Suppl; 1983; 97():41-8. PubMed ID: 6424396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethosuximide in the treatment of absence (peptit mal) seizures.
    Browne TR; Dreifuss FE; Dyken PR; Goode DJ; Penry JK; Porter RJ; White BG; White PT
    Neurology; 1975 Jun; 25(6):515-24. PubMed ID: 805382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of valproate monotherapy on spike-wave activity in generalized epilepsies (author's transl)].
    Stefan H; Hoffmann F; Burr W; Fröscher W; Penin H
    Nervenarzt; 1981 Dec; 52(12):707-14. PubMed ID: 6798478
    [No Abstract]   [Full Text] [Related]  

  • 9. An older drug for childhood absence epilepsy.
    Potera C
    Am J Nurs; 2010 Jun; 110(6):16. PubMed ID: 20505447
    [No Abstract]   [Full Text] [Related]  

  • 10. [Valproic acid -- clinical efficiency and serum concentration in the treatment of petit mal epilepsy in childhood (author's transl)].
    Fritsch G; Haidvogl M; Gleispach H; Ladurner G
    Padiatr Padol; 1981; 16(4):481-8. PubMed ID: 6795573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood serotonin in untreated petit-mal epileptics and influence of efficient treatment with either ethosuximide or valproate.
    Volanschi D; Luca N; Haţegan D; Ionescu G
    Neurol Psychiatr (Bucur); 1982; 20(1):67-70. PubMed ID: 6803347
    [No Abstract]   [Full Text] [Related]  

  • 12. A systematic review of treatment of typical absence seizures in children and adolescents with ethosuximide, sodium valproate or lamotrigine.
    Posner EB; Mohamed K; Marson AG
    Seizure; 2005 Mar; 14(2):117-22. PubMed ID: 15694565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproic acid (Depakene). A new anticonvulsant agent.
    Lewis JR
    JAMA; 1978 Nov; 240(20):2190-2. PubMed ID: 100622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Practical Guide to Treatment of Childhood Absence Epilepsy.
    Kessler SK; McGinnis E
    Paediatr Drugs; 2019 Feb; 21(1):15-24. PubMed ID: 30734897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled and comparative trials with valproate: United States.
    Ramsay RE
    Epilepsia; 1984; 25 Suppl 1():S40-3. PubMed ID: 6425045
    [No Abstract]   [Full Text] [Related]  

  • 16. Absence seizures in children.
    Posner E
    Clin Evid; 2005 Jun; (13):221-6. PubMed ID: 16135261
    [No Abstract]   [Full Text] [Related]  

  • 17. Pretreatment behavior and subsequent medication effects in childhood absence epilepsy.
    Shinnar RC; Shinnar S; Cnaan A; Clark P; Dlugos D; Hirtz DG; Hu F; Liu C; Masur D; Weiss EF; Glauser TA;
    Neurology; 2017 Oct; 89(16):1698-1706. PubMed ID: 28916534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethosuximide in childhood absence epilepsy--older and better.
    Vining EP
    N Engl J Med; 2010 Mar; 362(9):843-5. PubMed ID: 20200390
    [No Abstract]   [Full Text] [Related]  

  • 19. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.
    Posner EB; Mohamed K; Marson AG
    Cochrane Database Syst Rev; 2003; (3):CD003032. PubMed ID: 12917940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. When the past challenges the present: are older antiepileptic drugs still the best choice in childhood absence epilepsy?
    Arzimanoglou A; Ryvlin P; Perucca E
    Lancet Neurol; 2010 May; 9(5):457-9. PubMed ID: 20398853
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.